Johan Kördel has been elected as board director in Athera Biotechnologies AB, replacing Lennart Hansson who recently retired from Industrifonden. Professor Gunnar Olsson, former head of AstraZeneca CVD/GI Therapy area remains Chairman of the Board. Otto Skolling and Svein Mathisen remain as boarAlready a subscriber Login You have read all…